Axa S.A. Procept Bio Robotics Corp Transaction History
Axa S.A.
- $32.3 Billion
- Q3 2024
A detailed history of Axa S.A. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Axa S.A. holds 586,225 shares of PRCT stock, worth $49.1 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
586,225Holding current value
$49.1 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$405 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$292 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$128 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$104 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$98.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.73B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...